Briefing
Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor
EXTEND is a multicenter randomized phase 2 basket trial of standard of care with or without metastasis-directed local consolidative therapy in oligometastatic solid tumors. ClinicalTrials.gov API v2 on 13 Nov 2026: ACTIVE_NOT_RECRUITING, actual enrollment 380, start 2018-07-31, primary completion 2029-12-31. The JCO 2026 paper reports 350 randomly assigned and 334 per-protocol; those counts are not pooled with the registry figure.
- Design: Phase 2 · Active, not recruiting